Functional Assessment of the Infart-related Artery With Bioactive and Polymer-free Coronary Stents (The FUNCOMBO Trial)
NCT04202172 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2020-10-26
Summary
A total of 50 patients with ST-elevation myocardial infarction (STEMI) undergoing primary-percutaneous coronary intervention (PPCI) will be randomized to two different coronary stents: BIOFREEDOM vs. COMBO stent.
All patients will undergo to 6-month scheduled coronary angiography to evaluate the endothelial function response of the distal coronary segment and other functional parameters.
Conditions
- Endothelial Dysfunction
- Coronary Microvascular Disease
- Myocardial Infarction
Interventions
- PROCEDURE
-
Stent implantation in the infart-related artery in patients with ST elevation myocardial infarction
The 6-month scheduled coronary angiography will perform 3 interventions: 1. Endothelial function assessment with intracoronary acetyl-choline infusion. 2. Microcirculatory function assessment with a pressure wire during endovenous adenosine infusion. 3. Stent healing assessment using optical coherence tomography
Sponsors & Collaborators
-
Spanish Society of Cardiology
collaborator OTHER -
Institut d'Investigació Biomèdica de Bellvitge
lead OTHER
Principal Investigators
-
Josep Gomez Lara, MD PhD · Hospital Universitari de Bellvitge, L´Hospitalet de Llobregat, Spain
-
Neus Salvatella, MD · Hospital del Mar, Barcelona, Spain
-
Salvatore Brugaletta, MD PhD · Hospital Clinic, Barcelona, Spain
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-11-05
- Primary Completion
- 2020-03-01
- Completion
- 2020-09-01
- FDA Drug
- Yes
- FDA Device
- Yes
Countries
- Spain
Study Locations
More Related Trials
-
COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials
NCT02723981 ·Status: WITHDRAWN ·Phase: PHASE4
-
Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions
NCT02542007 ·Status: COMPLETED ·Phase: NA
-
Coroflex® ISAR NEO PMCF Study
NCT05698732 ·Status: RECRUITING
-
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
NCT00823212 ·Status: COMPLETED ·Phase: PHASE3
-
YUKON-drug-eluting Stent Below The Knee - Randomised Double-blind Study
NCT00664963 ·Status: COMPLETED ·Phase: PHASE4
-
DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity
NCT02175706 ·Status: UNKNOWN ·Phase: NA
-
Trial to Assess the Everolimus-Eluting Coronary Stent System (PROMUS Element) for Coronary Revascularization
NCT01342822 ·Status: UNKNOWN
-
Sort Out XI - Combo Stent Versus BioMatrix Alpha Stent
NCT03952273 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention.
NCT06214819 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents Versus Everolimus-Eluting Stents in Coronary Artery Disease Patients With Diabetes Mellitus Global
NCT04236609 ·Status: UNKNOWN ·Phase: NA
-
Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT
NCT01405287 ·Status: COMPLETED ·Phase: PHASE2
-
Long Term Safety Profile of the PRO-Kinetic ENERGY Coronary Stent System in Daily Clinical Practice
NCT01056120 ·Status: COMPLETED
-
Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease
NCT06710210 ·Status: RECRUITING ·Phase: NA
-
Everolimus- Versus Biolimus-Eluting Stents in All-Comers
NCT01472705 ·Status: COMPLETED
-
COMPARE-II- Vasomotion and Imaging Substudy
NCT01329237 ·Status: UNKNOWN ·Phase: PHASE4
-
Xience/Promus for Long Coronary Lesion Registry
NCT01147237 ·Status: UNKNOWN ·Phase: PHASE4
-
POST-dilatation to Improve Outcomes in Acute STEMI Patients Undergoing Primary With OCT Assessment
NCT02121223 ·Status: UNKNOWN ·Phase: NA
-
Adhesiveness of Coronary Drug-Eluting Stents to the Delivery Balloon-Catheter: A Randomized Comparison
NCT00279006 ·Status: UNKNOWN ·Phase: NA
-
Coronary Flow Reserve in Patients With Bio-active Stent or Everolimus-eluting Stent Implanted in Acute Coronary Syndrome
NCT01080872 ·Status: COMPLETED
-
First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis
NCT02236975 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Prospective multicEntric NonranDomized Registry
NCT02496169 ·Status: UNKNOWN ·Phase: NA
-
Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent
NCT00793221 ·Status: COMPLETED ·Phase: PHASE3
-
LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients
NCT06657326 ·Status: RECRUITING ·Phase: NA
-
Study of ABSORB Stent in Acute Myocardial Infarction
NCT02071342 ·Status: UNKNOWN
-
DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population
NCT01331707 ·Status: COMPLETED ·Phase: PHASE4